CEP70 and neoplasm: BiTE, a bispecific antibody, redirects T cells to tumor cells expressing specific antigens by linking two single-stranded variable fragments (scFv): one that recognizes tumor antigens and the other that recognizes CD3 molecules on T cells [52,53].